TNF-alpha in the Times

Dr. Thomas Stuttaford, writing in The Times, is extremely enthusiastic about TNF-α inhibitors for treating rheumatic conditions: "compared with current treatment, [this] is like the hydrogen bomb instead of the wartime 1,000-lb high-explosive bomb. . . . There is a whole group of these new drugs. I have seen more patients treated by Remicade (infliximab) than the others and in these patients the results have been astounding, their lives transformed."